David T Gilbertson

Summary

Affiliation: Chronic Disease Research Group
Country: USA

Publications

  1. ncbi Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
  2. ncbi The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Nephrol Dial Transplant 26:2934-9. 2011
  3. ncbi Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
  4. ncbi Projecting the number of patients with end-stage renal disease in the United States to the year 2015
    David T Gilbertson
    United States Renal Data System Coordinating Center University of Minnesota, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:3736-41. 2005
  5. ncbi Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
  6. ncbi Hemoglobin variability and mortality: confounding by disease severity
    Eric D Weinhandl
    Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 57:255-65. 2011
  7. ncbi Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis
    Yelena Slinin
    Veterans Administration Medical Center, Minneapolis, MN 55417, USA
    Am J Kidney Dis 58:583-90. 2011
  8. ncbi Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S71-7. 2009
  9. ncbi Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010
  10. ncbi Hospital treatment for fluid overload in the Medicare hemodialysis population
    Thomas J Arneson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 5:1054-63. 2010

Detail Information

Publications61

  1. ncbi Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
    ..4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I), 18.3%; intermediate-high (I-H), 31.7%, and low-high (L-H), 40.2%...
  2. ncbi The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Nephrol Dial Transplant 26:2934-9. 2011
    ..We aimed to describe vaccination rates between 2003-2005 and to study the effects on outcomes...
  3. ncbi Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
    ....
  4. ncbi Projecting the number of patients with end-stage renal disease in the United States to the year 2015
    David T Gilbertson
    United States Renal Data System Coordinating Center University of Minnesota, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:3736-41. 2005
    ..The financial and human resources that will be needed to care for these patients in 2015 will be considerably greater than in 2005...
  5. ncbi Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
    ..We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations...
  6. ncbi Hemoglobin variability and mortality: confounding by disease severity
    Eric D Weinhandl
    Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 57:255-65. 2011
    ..Adequate adjustment for confounding by disease severity is needed to estimate the association of hemoglobin level variability with mortality risk...
  7. ncbi Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis
    Yelena Slinin
    Veterans Administration Medical Center, Minneapolis, MN 55417, USA
    Am J Kidney Dis 58:583-90. 2011
    ..Few patients receive dietary counseling before end-stage renal disease onset; whether such counseling is associated with improved outcomes is unknown...
  8. ncbi Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S71-7. 2009
    ..A CKD screening approach targeting individuals 60 years and older or those with diabetes or hypertension likely would be useful from a public health standpoint...
  9. ncbi Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010
    ..These data suggest that increased use of peritoneal dialysis may benefit incident ESRD patients...
  10. ncbi Hospital treatment for fluid overload in the Medicare hemodialysis population
    Thomas J Arneson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 5:1054-63. 2010
    ..This study aimed to estimate the magnitude of fluid overload treatment episodes for the Medicare hemodialysis population in hospital settings, including emergency departments...
  11. ncbi Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year
    Yelena Slinin
    VA Medical Center 111J, One Veteran s Drive, Minneapolis, MN 55417, USA
    Clin J Am Soc Nephrol 5:1574-81. 2010
    ....
  12. ncbi Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Minneapolis, MN 55404, USA
    Am J Nephrol 34:298-308. 2011
    ..Appropriately designed observational studies are needed to clarify the association of ESA dosing with mortality risk...
  13. ncbi Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001
    Haifeng Guo
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Circulation 115:50-8. 2007
    ..Temporal trends regarding the epidemiology of atherosclerotic renovascular disease (ARVD) in dialysis populations are poorly defined...
  14. ncbi Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients
    Suying Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA
    Int Urol Nephrol 35:399-405. 2003
    ..76; P < 0.0001). CONCLUSION: In patients with persistently low hemoglobin values, optimizing urea clearance and a proactive approach to intravenous iron therapy may enhance epoetin responsiveness...
  15. ncbi Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 22:2247-55. 2007
    ..We aimed to determine if time required to reach 11 g/dl was associated with increased risk of hospitalization or death among incident dialysis patients...
  16. ncbi Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations
    James P Ebben
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:1205-10. 2006
    ..Hemoglobin levels in almost 90% of patients are in some degree of flux at any point in time, and the fluctuation is highly associated with clinical complications and provider practices...
  17. ncbi Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005
    Lih Wen Mau
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 55:549-57. 2010
    ..We examined trends in older incident hemodialysis patient characteristics and analyzed first-year post-dialysis therapy initiation medical costs...
  18. ncbi Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels
    Tricia L Roberts
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, MN 55404, USA
    Nephrol Dial Transplant 21:1652-62. 2006
    ..0212). CONCLUSIONS: Integrating factors predictive of anaemia improves overall prognostic discrimination. Propensity score adjustment refines the prognostic association of haemoglobin levels in haemodialysis patients...
  19. ncbi Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older
    Hassan N Ibrahim
    Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Nephrol Dial Transplant 24:3138-43. 2009
    ..Their impact on transfusion frequency in elderly chronic kidney disease (CKD) patients aged 65 years and older with non-dialysis-dependent CKD has not been studied...
  20. ncbi Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Hemodial Int 11:333-9. 2007
    ..Exceeding hemoglobin level targets has become widespread in the United States and is associated with changes in epoetin dosing practices...
  21. ncbi Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States
    Blanche M Chavers
    University of Minnesota, Department of Pediatrics, Mayo Mail Code 491, 420 Delaware Street SE, Minneapolis, MN 5545, USA
    J Am Soc Nephrol 18:952-9. 2007
    ..Pediatric KTx patients require infection surveillance after transplantation...
  22. ncbi Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: whites, blacks, hispanics, and asians
    A Marshall McBean
    Division of Health Services Research and Policy, University of Minnesota School of Public Health, MMC 97, Mayo Memorial Building, 420 Delaware St SE, Minneapolis, MN 55455, USA
    Diabetes Care 27:2317-24. 2004
    ..To examine diabetes prevalence, incidence, and mortality from 1993 to 2001 among fee-for-service Medicare beneficiaries > or = 67 years of age...
  23. ncbi Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    J Am Soc Nephrol 15:174-9. 2004
    ..Hemoglobin levels in U.S. hemodialysis and peritoneal populations are similar. However, erythropoietin doses are dramatically higher in hemodialysis patients...
  24. ncbi Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients
    Hassan N Ibrahim
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Clin J Am Soc Nephrol 4:623-9. 2009
    ..The authors aimed to determine prevalence of parenteral iron administration and its contribution to exceeding hemoglobin target levels...
  25. ncbi Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Pharmacotherapy 29:154-64. 2009
    ....
  26. ncbi Anemia and new-onset congestive heart failure in the general Medicare population
    Peter E Sandgren
    Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    J Card Fail 11:99-105. 2005
    ..Anemia also was associated with death in the year after new-onset CHF (adjusted hazard ratio, 1.28; P < .001). CONCLUSION: Anemia in the Medicare population is associated with the diagnosis and prognosis of new-onset CHF...
  27. ncbi Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Hemodial Int 11:442-7. 2007
    ..8 in 2003). While time to recovery of prehospitalization hemoglobin levels remained constant year to year, epoetin doses and ERI did not, suggesting that optimum perihospitalization anemia management practices have yet to be determined...
  28. ncbi Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators
    Charles A Herzog
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 68:818-25. 2005
    ..The objective of this retrospective cohort study was to determine ICD use in dialysis patients and impact on survival...
  29. ncbi The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 16:210-8. 2005
    ..Parathyroidectomy rates in U.S. hemodialysis patients increased between 1998 and 2002, a period in which the therapeutic armamentarium for preventing severe hyperparathyroidism expanded considerably...
  30. ncbi Predictors of ESA use in the non-dialysis chronic kidney disease population with anemia
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minn 55404, USA
    Nephron Clin Pract 111:c141-8. 2009
    ..Anemia is a common complication of chronic kidney disease (CKD), but anemia treatment may be less comprehensive than guidelines suggest...
  31. ncbi Hemoglobin level variability: anemia management among variability groups
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minn 55404, USA dgilbertson cdrg org
    Am J Nephrol 30:491-8. 2009
    ..We aimed to describe the influence of anemia management interventions (erythropoiesis-stimulating agents [ESAs], intravenous iron, and transfusions) on hemoglobin variability...
  32. ncbi Mortality from cancer among US hemodialysis patients, 1995-2005
    Robert N Foley
    Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Nephrol 31:518-26. 2010
    ..As ESA doses have more than tripled in the USA since ESAs were introduced, we aimed to compare annual trends in cancer-specific mortality rates among incident maintenance hemodialysis patients...
  33. ncbi Anemia and cost in Medicare patients with congestive heart failure
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minnesota, Minneapolis, MN 55404, USA
    Congest Heart Fail 12:302-6. 2006
    ..25 (95% confidence interval, 1.2546-1.2548). Anemia, a common association of CHF in elderly patients, is an antecedent association of increased societal medical expenditure...
  34. ncbi An improved comorbidity index for outcome analyses among dialysis patients
    Jiannong Liu
    United States Renal Data System Coordinating Center, 914 South 8th Street, Minneapolis, MN 55404, USA
    Kidney Int 77:141-51. 2010
    ..Our index performance was almost identical to the individual comorbid conditions regarding model fit, predictive ability, and effect on inference, and it outperformed the widely used Charlson Comorbidity Index...
  35. ncbi Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrology (Carlton) 15:37-42. 2010
    ..Such assessment is needed to reduce the high burden of ESRD on national health-care systems, which can only be addressed by early screening and active treatment...
  36. ncbi Survival of kidney transplantation patients in the United States after cardiac valve replacement
    Alok Sharma
    Department of Internal Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, USA
    Circulation 121:2733-9. 2010
    ..This study aimed to assess survival of US kidney transplantation patients after cardiac valve replacement and to compare associations of valve selection...
  37. ncbi CKD surveillance using administrative data: impact on the health care system
    Allan J Collins
    US Renal Data System Coordinating Center, University of Minnesota, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S27-36. 2009
    ..Long-term trend analyses are needed to determine whether morbidity and mortality rates change based on greater detection and treatment efforts...
  38. ncbi EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN, USA
    Am J Kidney Dis 49:135-42. 2007
    ....
  39. ncbi Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
    ....
  40. ncbi Influenza vaccine delivery and effectiveness in end-stage renal disease
    David T Gilbertson
    United States Renal Data System Coordinating Center and Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 63:738-43. 2003
    ..This report assessed the frequency and effectiveness of influenza vaccination, while also assessing disparities in vaccination rates in the ESRD population...
  41. ncbi Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 50:803-12. 2007
    ..Levocarnitine deficiency in hemodialysis patients is common. Although the effect of intravenous levocarnitine therapy was studied in small trials, the effect on global outcomes in larger populations is unclear...
  42. ncbi Use of hospice in the United States dialysis population
    Anne M Murray
    Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:1248-55. 2006
    ..Increased hospice use may enable more dialysis patients to die at home, with substantial cost savings. Research regarding additional benefits of hospice care for dialysis patients is needed...
  43. ncbi The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis
    Allan J Collins
    U S Renal Data System, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:S5-11. 2009
    ..Public health programs, including the new Medicare chronic kidney disease education benefit, are needed to promote better care of patients who may need dialysis to reduce the high morbidity and mortality in the first year...
  44. ncbi Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention?
    Charles A Herzog
    Cardiovascular Special Studies Center, United States Renal Data System, 914 South 8th Street, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:2629-33. 2008
    ..We analyzed cause-specific mortality of dialysis patients after coronary revascularization...
  45. ncbi Economic effect of following HbA1c testing practice guidelines in the elderly Medicare population: an instrumental variable analysis
    Suying Li
    United States Renal Data System Coordinating Center, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Med Qual 25:202-10. 2010
    ....
  46. ncbi Assessment of pure red cell aplasia in US dialysis patients: the limits of the Medicare data
    Allan J Collins
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 43:464-70. 2004
    ..We investigated the frequency of diagnosis codes that include pure red cell aplasia (PRCA) in the Medicare end-stage renal disease data...
  47. ncbi Septicemia in the United States dialysis population, 1991 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 206, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 15:1038-45. 2004
    ..7, 2.0, 2.0, and 1.6 after 5 yr, respectively. Septicemia, which is associated with increased cardiovascular and death risk, has become more common in dialysis patients in the United States...
  48. ncbi Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies
    Jiannong Liu
    United States Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 81:341-50. 2012
    ..Results from the DaVita data were consistent with the simulation. Careful consideration of methodology is needed in observational analyses with time-dependent treatment...
  49. ncbi Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction
    Areef Ishani
    Section of Nephrology, Department of Medicine, Minneapolis VAMC, One Veterans Drive, Minneapolis, MN 55417, USA
    J Am Coll Cardiol 45:391-9. 2005
    ..We aimed to investigate the impact of angiotensin-converting enzyme inhibitors (ACEIs) on hematocrit values in those with heart failure, and the relationship between incident anemia and mortality...
  50. ncbi Cancer after kidney transplantation in the United States
    Bertram L Kasiske
    Department of Medicine, Hennepin County Medical Center, Minneapolis, MN, USA
    Am J Transplant 4:905-13. 2004
    ..The rates for most malignancies are higher after kidney transplantation compared with the general population. Cancer should continue to be a major focus of prevention in kidney transplantation...
  51. ncbi Long interdialytic interval and mortality among patients receiving hemodialysis
    Robert N Foley
    United States Renal Data System, University of Minnesota, Minneapolis, MN 55404, USA
    N Engl J Med 365:1099-107. 2011
    ..Given these problems, we hypothesized that a long interdialytic interval is associated with adverse events in patients receiving hemodialysis...
  52. ncbi Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure
    Steven R Goldsmith
    Cardiology Division, Hennepin County Medical Center, Minneapolis, Minnesota 55415, USA
    J Card Fail 17:982-9. 2011
    ..This study investigated the renal and neurohormonal effects of loop diuretics, the mixed vasopressin antagonist conivaptan, and the combination in patients with chronic stable HF...
  53. ncbi A comparison of transplant outcomes in peritoneal and hemodialysis patients
    Jon J Snyder
    Minneapolis Medical Research Foundation, 914 S 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    Kidney Int 62:1423-30. 2002
    ..Therefore, we studied the effects of pre-transplant dialysis modality on outcomes in a large United States cohort...
  54. ncbi Does predialysis nephrology care influence patient survival after initiation of dialysis?
    Samina S Khan
    Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 67:1038-46. 2005
    ....
  55. ncbi Clinical epidemiology of long-bone fractures in patients receiving hemodialysis
    Thomas M Kaneko
    Department of Neurosurgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
    Clin Orthop Relat Res 457:188-93. 2007
    ..Long-bone fractures are common in patients receiving dialysis; their adverse prognostic implications may be linked to major cardiovascular and infectious events...
  56. ncbi Effect of comorbidity on the increased mortality associated with early initiation of dialysis
    Waqar H Kazmi
    Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 46:887-96. 2005
    ..Additional research is required to determine the reasons for poor survival in patients who start dialysis therapy with significant residual renal function...
  57. ncbi General medical care among patients with chronic kidney disease: opportunities for improving outcomes
    Annamaria T Kausz
    Division of Nephrology, Tufts New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
    J Am Soc Nephrol 16:3092-101. 2005
    ..This study provides further evidence that patients with CKD may not be receiving general health and CKD care according to current recommendations...
  58. ncbi Overview of vaccination in chronic kidney disease
    Annamaria T Kausz
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Adv Chronic Kidney Dis 13:209-14. 2006
    ..However, vaccination rates are relatively low. Given the accumulating evidence of benefit, continuing quality improvement programs focused on increasing vaccination rates in patients with all levels of CKD are needed...
  59. ncbi Trends and disparities among diabetes-complicated births in Minnesota, 1993-2003
    Heather M Devlin
    Minnesota Diabetes Program, Minnesota Department of Health, PO Box 64882, St Paul, MN 55164 0882, USA
    Am J Public Health 98:59-62. 2008
    ..8, respectively). Increases were significant in all demographic groups except gestational diabetes among American Indian mothers, and disparities worsened among all groups. Targeted interventions and surveillance improvements are needed...
  60. ncbi The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population
    Claudine T Jurkovitz
    Christiana Care Center for Outcomes Research, Christiana Care Health System, Newark, DE 19713, USA
    Am J Kidney Dis 51:S3-12. 2008
    ..This report aims to detail demographic characteristics of KEEP participants and compare them with characteristics of participants in the National Health and Nutrition Examination (NHANES) 1999-2004...
  61. ncbi Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis
    Philip A Kalra
    Department of Renal Medicine, Hope Hospital, Salford, United Kingdom
    Kidney Int 68:293-301. 2005
    ..Absolute cardiovascular risk exceeds that of renal replacement therapy. Renal revascularization is used selectively and shows inconsistent associations with cardiovascular outcomes, renal replacement therapy, and death...